Success Metrics

Clinical Success Rate
86.9%

Based on 279 completed trials

Completion Rate
87%(279/321)
Active Trials
54(11%)
Results Posted
39%(109 trials)
Terminated
42(8%)

Phase Distribution

Ph phase_1
47
9%
Ph phase_3
94
18%
Ph not_applicable
69
14%
Ph phase_4
170
33%
Ph phase_2
95
19%
Ph early_phase_1
19
4%

Phase Distribution

66

Early Stage

95

Mid Stage

264

Late Stage

Phase Distribution494 total trials
Early Phase 1First-in-human
19(3.8%)
Phase 1Safety & dosage
47(9.5%)
Phase 2Efficacy & side effects
95(19.2%)
Phase 3Large-scale testing
94(19.0%)
Phase 4Post-market surveillance
170(34.4%)
N/ANon-phased studies
69(14.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.3%

279 of 339 finished

Non-Completion Rate

17.7%

60 ended early

Currently Active

54

trials recruiting

Total Trials

511

all time

Status Distribution
Active(67)
Completed(279)
Terminated(60)
Other(105)

Detailed Status

Completed279
unknown105
Recruiting44
Terminated42
Withdrawn18
Not yet recruiting12

Development Timeline

Analytics

Development Status

Total Trials
511
Active
54
Success Rate
86.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 119 (3.8%)
Phase 147 (9.5%)
Phase 295 (19.2%)
Phase 394 (19.0%)
Phase 4170 (34.4%)
N/A69 (14.0%)

Trials by Status

withdrawn184%
enrolling_by_invitation10%
active_not_recruiting102%
not_yet_recruiting122%
recruiting449%
unknown10521%
completed27955%
terminated428%

Recent Activity

Clinical Trials (511)

Showing 20 of 511 trialsScroll for more
NCT04078568Phase 3

Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease

Completed
NCT07525635Early Phase 1

Aspirin Dosing in Pregnancy

Not Yet Recruiting
NCT02965703Phase 2

Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma

Active Not Recruiting
NCT05418556Phase 4

Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent

Recruiting
NCT03574909Phase 3

IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes

Completed
NCT06757764Phase 4

The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis

Recruiting
NCT06650488Phase 4

Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

Recruiting
NCT03796156Phase 3

Aspirin to Target Arterial Events in Chronic Kidney Disease

Terminated
NCT06378398Early Phase 1

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

Completed
NCT06451198Phase 4

IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome

Recruiting
NCT04295486Phase 2

Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty

Recruiting
NCT05633810Phase 3

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

Recruiting
NCT04809818Phase 1

A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects

Completed
NCT06655376Phase 4

Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device

Recruiting
NCT07431762Phase 4

Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Heart Valve Replacement

Not Yet Recruiting
NCT03907046Phase 3

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Recruiting
NCT05036109Not Applicable

DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease

Completed
NCT01275300Not Applicable

Biosynthesis of PGD2 in Vivo

Completed
NCT06676280Phase 4

ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography

Recruiting
NCT07373756Phase 4

Randomized Controlled Study to Compare Efficacy of Aspirin 75mg and 150mg In the Prevention of Preeclampsia In High Risk Pregnant Women

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
511